Clinical Diagnostics Technology & Disease Research News | 360Dx
WEBEmerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
About Us - 360Dx
WEBAbout Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Foundation Medicine Test Approved by FDA as CDx for Itovebi in …
WEB18 hours ago · NEW YORK – Roche subsidiary Foundation Medicine announced Friday that its FoundationOne Liquid CDx assay has received approval from the US Food and Drug Administration for use as a companion diagnostic with Genetech's Itovebi (inavolisib) in combination with Pfizer's Ibrance (palbociclib) and fulvestrant for patients with breast cancer.. The test and drug combination are approved for use in ...
Diagnostic Technologies and Applications - 360Dx
WEBTexas Hospital CEO to Pay $5.3M to Settle Allegations of Kickbacks for Testing. Jeffrey Madison had been accused of participation in a scheme to pay kickbacks to physicians for testing referrals and billing healthcare programs for the tests. Oct 3, 2024.
USC Team Counts Circulating Tumor Cells to Predict Treatment …
WEB18 hours ago · NEW YORK – A team of researchers at the University of Southern California have used a commercial blood test to count circulating tumor cells (CTCs) and predict how prostate cancer patients will respond to certain therapies and their survival outcomes. Menarini's US Food and Drug Administration ...
Magellan Sentenced to Pay $42M for Selling Faulty Blood-Lead …
WEB5 hours ago · NEW YORK – The US Department of Justice on Thursday said that Magellan Diagnostics has been ordered by a federal court to pay $42 million on charges that the company concealed malfunctions in instruments that it sold for measuring lead levels in blood. The Billerica, Massachusetts-based firm had …
In Brief This Week: ADLM, Labcorp, Foresight Diagnostics, T2 …
WEB18 hours ago · T2 Biosystems and pRxcision this week announced they will comarket T2 Bio's rapid, direct-from-blood diagnostics and pRxcision's platform. The deal aims to deliver a "comprehensive approach" to managing bloodstream infections and sepsis by providing hospitals the ability to rapidly identify pathogens directly from blood in hours, compared to days with other methods, along with real-time ...
Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer …
WEB1 hour ago · NEW YORK – Digital pathology diagnostics firm Stratipath continues to establish itself in the clinic with its breast cancer prognostic test with recent data demonstrating strong performance in a cohort of more than 2000 breast cancer cases. The Swedish firm, founded in 2019 as a spinout from the Karolinska Institute, received a …
Labcorp Inks Deal With NowDx to Become Exclusive Distributor of …
WEB1 day ago · NEW YORK – Laboratory Corporation of America said Thursday that it has signed an agreement with NowDiagnostics (NowDx) to serve as the exclusive US distributor for its First to Know Syphilis Test. The First to Know test received US Food and Drug Administration authorization in August, making it the first over-the-counter syphilis test to …
Breaking News - 360Dx
WEBOct 4, 2024 · Texas Lab Owner Indicted for COVID-19 Fraud Scheme. According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million. Sep 26, 2024.